NO893078D0 - Indolderivater. - Google Patents

Indolderivater.

Info

Publication number
NO893078D0
NO893078D0 NO893078A NO893078A NO893078D0 NO 893078 D0 NO893078 D0 NO 893078D0 NO 893078 A NO893078 A NO 893078A NO 893078 A NO893078 A NO 893078A NO 893078 D0 NO893078 D0 NO 893078D0
Authority
NO
Norway
Prior art keywords
indole derivatives
indole
derivatives
Prior art date
Application number
NO893078A
Other languages
English (en)
Other versions
NO893078L (no
NO173652C (no
NO173652B (no
Inventor
Tatsuya Kon
Shiro Kato
Toshiya Morie
Tadahiko Karasawa
Naoyuki Yoshida
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of NO893078D0 publication Critical patent/NO893078D0/no
Publication of NO893078L publication Critical patent/NO893078L/no
Publication of NO173652B publication Critical patent/NO173652B/no
Publication of NO173652C publication Critical patent/NO173652C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO893078A 1988-07-29 1989-07-28 Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt indazol-3-karboksylsyrederivat NO173652C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19190488 1988-07-29
JP32298688 1988-12-20

Publications (4)

Publication Number Publication Date
NO893078D0 true NO893078D0 (no) 1989-07-28
NO893078L NO893078L (no) 1990-01-30
NO173652B NO173652B (no) 1993-10-04
NO173652C NO173652C (no) 1994-01-12

Family

ID=26506977

Family Applications (1)

Application Number Title Priority Date Filing Date
NO893078A NO173652C (no) 1988-07-29 1989-07-28 Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt indazol-3-karboksylsyrederivat

Country Status (11)

Country Link
US (1) US5017573A (no)
EP (1) EP0358903A3 (no)
JP (2) JPH0655738B2 (no)
KR (1) KR910002839A (no)
AU (1) AU621642B2 (no)
DK (1) DK374289A (no)
FI (1) FI893592A (no)
HU (1) HU204816B (no)
NO (1) NO173652C (no)
NZ (1) NZ230068A (no)
PT (1) PT91287B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
IL117438A (en) * 1995-03-16 2001-12-23 Lilly Co Eli Indazolecarboxamides, their preparation and pharmaceutical compositions containing them
US5654320A (en) * 1995-03-16 1997-08-05 Eli Lilly And Company Indazolecarboxamides
WO1996038420A1 (fr) * 1995-05-31 1996-12-05 Nisshin Flour Milling Co., Ltd. Derives de l'indazole a groupe amino monocyclique
AU700635B2 (en) * 1995-07-28 1999-01-07 Dainippon Pharmaceutical Co. Ltd. (R)-5-bromo-N-(1-ethyl-4-methylhexahydro-1H-1,4-diazepin-6-Y L)-2-methoxy-6-methylamino-3-pyridinecarboxamide, process for preparation thereof and pharmaceutical composition containing said compound.
US6046185A (en) * 1996-07-11 2000-04-04 Inflazyme Pharmaceuticals Ltd. 6,7-oxygenated steroids and uses related thereto
US6069152A (en) * 1997-10-07 2000-05-30 Eli Lilly And Company 5-HT4 agonists and antagonists
GB9721139D0 (en) * 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
US5914405A (en) * 1997-10-07 1999-06-22 Eli Lilly And Company Process for preparing 3-substituted indazoles
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US7666867B2 (en) * 2001-10-26 2010-02-23 University Of Connecticut Heteroindanes: a new class of potent cannabimimetic ligands
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
US7728006B2 (en) * 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
TW200621237A (en) 2004-11-01 2006-07-01 Wyeth Corp [(1-h-indazol-3-yl)methyl]phenols and (hydroxyphenyl)(1h-indazol-3-yl)methanones
DE602005016446D1 (de) * 2004-11-05 2009-10-15 Theravance Inc 5-HT4-Rezeptoragonistenverbindungen
EP1807423B1 (en) * 2004-11-05 2009-05-20 Theravance, Inc. Quinolinone-carboxamide compounds
WO2006069125A1 (en) * 2004-12-22 2006-06-29 Theravance, Inc. Indazole-carboxamide compounds
US7446114B2 (en) * 2005-03-02 2008-11-04 Theravance, Inc. Quinolinone compounds as 5-HT4 receptor agonists
ES2432618T3 (es) 2009-05-20 2013-12-04 Inserm (Institut National De La Santé Et De La Recherche Medicale) Antagonistas del receptor 5-HT3 de serotonina para usar en el tratamiento o prevención de una patología del oído interno con déficit vestibular
SI2432467T1 (en) 2009-05-20 2018-06-29 Inserm (Institut National De La Sante Et De La Recherche Medicale) ANTAGONIST RECEPTOR SEROTONINA 5-HT3 FOR THE USE IN THE TREATMENT OF LEASE VESTIBULAR DISEASES
JOP20130213B1 (ar) 2012-07-17 2021-08-17 Takeda Pharmaceuticals Co معارضات لمستقبلht3-5
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1069122A (en) * 1975-11-11 1980-01-01 W.R. Grace And Co. Preparation of dialkali metal hexahydropyrimidine-1, 3-diacetate and dialkalimetal 5-hydroxyhexahydropyrimidine-1, 3-diacetate
JPS5925785B2 (ja) * 1976-01-01 1984-06-21 山之内製薬株式会社 新規なカルボン酸アミド誘導体
US4207327A (en) * 1977-08-19 1980-06-10 A. H. Robins Company, Inc. N-(4-Pyrazolidinyl)benzamides and their amino precursors
DE3166987D1 (en) * 1980-09-18 1984-12-06 Asahi Chemical Ind 3-aminoindazole derivatives and process for preparation thereof
CA1220141A (en) * 1981-06-13 1987-04-07 John R. Fozard Treatment of migraine with tropyl benzoate derivatives
FR2531083B1 (fr) * 1982-06-29 1986-11-28 Sandoz Sa Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
JPS60123485A (ja) * 1983-12-08 1985-07-02 Yoshitomi Pharmaceut Ind Ltd インド−ル−3−カルボキサミド誘導体
ATE61054T1 (de) * 1985-01-23 1991-03-15 Hoechst Roussel Pharma 3-piperidinyl- 1h-indazole, verfahren zu deren herstellung und deren anwendung als arzneimittel.
DE3687080T2 (de) * 1985-04-27 1993-03-25 Beecham Group Plc Azabicyclononyl-indazol-carboxamid mit 5-ht-antagonistischer wirkung.
GB8623142D0 (en) * 1986-09-26 1986-10-29 Beecham Group Plc Compounds
GB8520616D0 (en) * 1985-08-16 1985-09-25 Beecham Group Plc Compounds
GB8527052D0 (en) * 1985-11-02 1985-12-04 Beecham Group Plc Compounds
ES2053451T3 (es) * 1986-01-07 1994-08-01 Beecham Group Plc Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles.
EP0235878A3 (en) * 1986-01-16 1989-06-14 Beecham Group Plc Novel compounds
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
JPH01117860A (ja) * 1987-10-30 1989-05-10 Dainippon Pharmaceut Co Ltd 安息香酸アミド誘導体
EP0410509A1 (en) * 1989-07-25 1991-01-30 Duphar International Research B.V New substituted 1H-indazole-3-carboxamides
US4954503A (en) * 1989-09-11 1990-09-04 Hoechst-Roussel Pharmaceuticals, Inc. 3-(1-substituted-4-piperazinyl)-1H-indazoles

Also Published As

Publication number Publication date
DK374289D0 (da) 1989-07-28
NO893078L (no) 1990-01-30
JP2898139B2 (ja) 1999-05-31
HU204816B (en) 1992-02-28
JPH0655738B2 (ja) 1994-07-27
NZ230068A (en) 1991-07-26
DK374289A (da) 1990-01-30
US5017573A (en) 1991-05-21
JPH02256670A (ja) 1990-10-17
EP0358903A3 (en) 1992-03-04
FI893592A (fi) 1990-01-30
KR910002839A (ko) 1991-02-26
FI893592A0 (fi) 1989-07-27
EP0358903A2 (en) 1990-03-21
PT91287A (pt) 1990-02-08
NO173652C (no) 1994-01-12
AU621642B2 (en) 1992-03-19
JPH0592959A (ja) 1993-04-16
AU3910389A (en) 1990-02-01
PT91287B (pt) 1995-03-01
HUT52093A (en) 1990-06-28
NO173652B (no) 1993-10-04

Similar Documents

Publication Publication Date Title
DE122004000043I1 (de) Carbostryril-Derivate.
ATE74125T1 (de) Didehydro-vitamin d3-derivate.
DE68910421D1 (de) DC-88A-Derivate.
NO893078L (no) Indolderivater.
DK0411150T3 (da) Indolderivater
DE58901056D1 (de) Dehydrocholecalciferolderivate.
DE59005241D1 (de) Indolderivate.
DE3872153D1 (de) 25-hydroxy-vitamin-d3-derivate.
ATE126800T1 (de) Neplanocinderivate.
FI883963A (fi) Isoxazol- -karbolinderivat.
ATE99694T1 (de) Antiparasitaere derivate.
DE68911192D1 (de) Phosphonoalkylpurin-Derivate.
DE58903265D1 (de) Fluorcyclopropyl-derivate.
ATE102624T1 (de) Makrolide derivate.
DK647289D0 (da) Annellerede indol-derivater
DE68914223T2 (de) Mitomycinderivate.
DE68913856T2 (de) Cycloalkylthiazol-Derivate.
DE3861208D1 (de) Hydroxyalkyl-triazolyl-derivate.
NO892714D0 (no) Substituerte azacykloheksylderivater.
FI895021A0 (fi) Anordning foer utfoerande av membransepareringsprocesser.
DE58900371D1 (de) 3-cyano-4-phenyl-pyrrol-derivate.
DE3866371D1 (de) Diphenylaethylen-derivate.
DE3863447D1 (de) Aminoethylphosphinsaeure-derivate.
DE3884482D1 (de) Thiapentanamid-derivate.
DE3881146T2 (de) Thiazetidin-Derivate.